EVALUATION OF MAGE-3 GENE m-RNA IN BLOOD AS POTENTIAL BIOCHEMICAL MARKER FOR HCC PATIENTS

MAGE-3 And -4 Genes as Possible Markers for Early Detection of Metastases in HCV Egyptian Patients Complicated By HCC

Molecular evaluation of Hepatocyte Growth Factor (HGF) as a potential Biomarker to detect Hepatocellular Carcinoma

Plasma albumin m RNA as anon invasive Marker to predict liver injury in chronic Hepatitis C and Hepatocellular carcinoma patients

Evaluation of Transforming Growth Factor- β 1 Gene Expression and Polymorphism in Diagnosis of Hepatocellular Carcinoma in HCV-Infected Patients

Genetic Markers for Early Detection of Cirrhotic-HCV and Non-Cirrhotic-HCV

Assessing TGF β1 Gene Expression as a Prognostic Marker for Hepatocellular Carcinoma Development in HCV patients receiving Direct-Acting Antiviral (DAAs) Therapy

Vitronectin (VTN): A Novel Diagnostic and Prognostic Marker for Hepatocellular Carcinoma (HCC) on Top of Chronic Hepatitis C Virus Related Diseases

Angiopoietin-2 as a diagnostic biomarker for Liver cirrhosis and Hepatocellular Carcinoma

Serum Level of Golgi Protein 73 as a Tumor Marker in Patients with Hepatocellular Carcinoma and Hepatitis C Virus-Related Liver Cirrhosis